Celgene establishes global patent portfolio for small molecule pharmaceuticals

January 2004

On behalf of Celgene Corporation, Jones Day assisted with global patent prosecution strategy and portfolio development relating to small molecule pharmaceuticals.

For additional information about this matter, please contact: Anthony M. Insogna, Martin Weber

Client(s): Celgene Corporation
Office(s): Atlanta, Munich, San Diego